VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline

Xlife Sciences AG / Key word: Mergers & Acquisitions/Takeover

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
29-Dec-2023 / 17:45 CET/CEST

Release of an ad hoc...

Related Keywords

Christoph Antz ,Oliverr Baumann ,Synimmune Gmb ,Xlife Sciences ,Synimmune Gmbh ,Acute Myeloid Leukemia ,Acute Myeloid ,Shareholders Meeting ,Year Report ,Markets ,